首页>
外国专利>
Fusion protein SLIT2D2-HSA and its use in treatment of sepsis
Fusion protein SLIT2D2-HSA and its use in treatment of sepsis
展开▼
机译:融合蛋白SLIT2D2-HSA及其在败血症治疗中的应用
展开▼
页面导航
摘要
著录项
相似文献
摘要
Disclosed is a fusion protein Slit2D2-HSA formed by fusion of a Slit2D2 polypeptide and a human serum albumin HSA, and use thereof for the manufacture of a medicament for prophylaxis and/or treatment of sepsis, and the said fusion protein Slit2D2-HSA retains the pharmacological activities of Slit2 in inhibition of neutrophil migration and treatment of sepsis, and has an improved stability, prolonged half-life and improved therapeutic effect of sepsis. Compared with protein of Slit2, the polypeptide of Slit2D2 has a smaller molecular weight which is much easier to be purified and separated in preparation and used in the development of drugs.
展开▼